Revolution Medicines, Inc. (RVMD)

Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $30.97 billion. The enterprise value is $29.50 billion.

Market Cap	30.97B
Enterprise Value	29.50B

Important Dates

The last earnings date was Wednesday, May 6, 2026, after market close.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

RVMD has 212.60 million shares outstanding. The number of shares has increased by 10.96% in one year.

Current Share Class	212.60M
Shares Outstanding	212.60M
Shares Change (YoY)	+10.96%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	88.13%
Float	194.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	288.34
PB Ratio	19.44
P/TBV Ratio	21.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.80, with a Debt / Equity ratio of 0.29.

Current Ratio	6.80
Quick Ratio	6.59
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-38.07

Financial Efficiency

Return on equity (ROE) is -76.67% and return on invested capital (ROIC) is -41.78%.

Return on Equity (ROE)	-76.67%
Return on Assets (ROA)	-37.53%
Return on Invested Capital (ROIC)	-41.78%
Return on Capital Employed (ROCE)	-70.61%
Weighted Average Cost of Capital (WACC)	11.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.55M
Employee Count	883
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +268.95% in the last 52 weeks. The beta is 1.41, so RVMD's price volatility has been higher than the market average.

Beta (5Y)	1.41
52-Week Price Change	+268.95%
50-Day Moving Average	120.50
200-Day Moving Average	81.77
Relative Strength Index (RSI)	58.13
Average Volume (20 Days)	2,977,028

Short Selling Information

The latest short interest is 12.80 million, so 6.02% of the outstanding shares have been sold short.

Short Interest	12.80M
Short Previous Month	13.39M
Short % of Shares Out	6.02%
Short % of Float	6.59%
Short Ratio (days to cover)	3.12

Income Statement

Revenue	n/a
Gross Profit	-1.13B
Operating Income	-1.39B
Pretax Income	-1.37B
Net Income	-1.37B
EBITDA	-1.38B
EBIT	-1.39B
Earnings Per Share (EPS)	-$7.12

Balance Sheet

The company has $1.91 billion in cash and $437.27 million in debt, with a net cash position of $1.47 billion or $6.92 per share.

Cash & Cash Equivalents	1.91B
Total Debt	437.27M
Net Cash	1.47B
Net Cash Per Share	$6.92
Equity (Book Value)	1.50B
Book Value Per Share	7.49
Working Capital	1.68B

Cash Flow

In the last 12 months, operating cash flow was -$1.06 billion and capital expenditures -$14.26 million, giving a free cash flow of -$1.07 billion.

Operating Cash Flow	-1.06B
Capital Expenditures	-14.26M
Depreciation & Amortization	8.44M
Net Borrowing	n/a
Free Cash Flow	-1.07B
FCF Per Share	-$5.04

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.96%
Shareholder Yield	-10.96%
Earnings Yield	-4.43%
FCF Yield	-3.46%

Analyst Forecast

The average price target for RVMD is $181.30, which is -0.78% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$181.30
Price Target Difference	-0.78%
Analyst Consensus	Strong Buy
Analyst Count	21
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1